Cyclobenzaprine Hydrochloride
- Product NDC
- 0615-3520
- 11-digit product format
- 006153520
- Labeler code
- 0615
- Product ID
- 0615-3520_3cdef1be-879c-49a7-817e-e4fdc171168c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclobenzaprine hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077797
- Marketing category
- ANDA
- Marketing start
- 2007-02-28
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-3520-05 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |
| 0615-3520-30 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |
| 0615-3520-39 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |
| 0615-3520-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |
| 0615-3520-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |
| 0615-3520-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-712c-f424-e053-dadaa90a57ce | 7d94cbbf-b090-465b-9cf4-870db279d8fe |